Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: gib major surgical or invasive procedure: egd s/p banding of varices history of present illness: 50y/o f with metastatic breast cancer to liver, patient of dr. who has been treated with 8 cycles of caf, alternating xeloda/taxotere, caboplatin and gemcitabine and recently has been treated with taxol for last month. avastin was added as well, first and only dose . she as seen in heme/ clinic today by dr. who sent her to the ed for c/o one week of black stools. she has been having stools per day that have been soft, black and sticky. she usually has stools per day. no diarrhea, no hematochezia. she denies any lightheadedness of dizzyness but states that just yesterday she noted sob with walking up one flight of stairs. no chest pain. no vomiting, no hematuria, +intermittent nausea and axiety. last week she also had one episode of confusion and forgetfullness which resolved, has not had any other episodes since. no c/o morning ha's, she does get tension headaches frequently which have not changed in character. she denies any visual changes or blurryness, no dysphagia, no odynophagia, no epistaxis, no sob at rest, no abd pain, no ruq pain, no back pain, no dysuria, no hematuria. patient does have external hemorrhoids which cause her pain often with her bm's. she has noticed increased abd girth over the past week. in dr. office her hct was 16, baseline mid 30's. guiac positive in office. in ed she was guiac negative, ngl was negative with 600cc. last dark stool yesterday. she was given 4 units of blood in the ed, started on protonix 40mg, given ativan 1mg x2, and annusol cream. past medical history: 1. breast cancer: -breast augmentation in 79 w/ silicone implants, implants replaced 2 years ago with saline implants. -diagnosed w/ breast cancer after noted sharp pains in l breast, skin color changes, and mass appreciated by pcp in breast. -er negative, pr negative, her2/neu negative 2. adhd social history: no tob, occ etoh. financial consultant, lives with her husband and 4 children family history: lung ca in sister at age 29, father died of prostate cancer at age 84, maternal grandparents both died of throat cancer. physical exam: pe: t: 98.4, p: 107, bp: 116/70, r: 20, sats: 100% gen: pale thin lady, nad heent: alopecia appreciated, eomi, perrla, sclera anicteric, conj clear, mmm, o/p clear cv: rrr, no m/r/g pulm: cta b/l, crackles appreciated at bases but clear with cough. good insp effort. abd: distended, round, +bs, mild ascites(+fluid shift), nt/nd, unable to appreciated liver or spleen. ext: no c/c/e, dp/pt +2 b/l. neuro: cn ii-xii grossly intact, sensation grossly intact to light touch, strenght in all four ext flex/ext. cerebellar: ftn/ intact. pertinent results: admit labs: 11:35am blood wbc-4.5# rbc-1.56*# hgb-5.2*# hct-16.2*# mcv-104* mch-33.6* mchc-32.4 rdw-17.2* plt ct-160# 01:10pm blood fibrino-252 11:35am blood gran ct-2780 03:50pm blood ret aut-2.6 11:35am blood glucose-123* urean-10 creat-0.4 na-137 k-3.8 cl-105 hco3-25 angap-11 11:35am blood alt-45* ast-48* ld(ldh)-424* alkphos-142* totbili-0.5 02:30pm blood caltibc-217* hapto-126 ferritn-585* trf-167* 11:35am blood ca 27.29-88 . d/c cbc: 07:15am blood wbc-3.1* rbc-4.14* hgb-13.6 hct-38.3 mcv-93 mch-32.8* mchc-35.5* rdw-17.9* plt ct-107* . hepatitis w/u: hbsab-positive hbcab-pnd . liver u/s w/ duplex: impression: 1. portal vein patent, demonstrating hepatopetal flow. 2. liver diffusely infiltrated with metastatic disease. 3. large amount of ascites. . egd: varices at the lower third of the esophagus erythema and congestion in the stomach compatible with portal gastropathy . mri brain: final read pending at discharge brief hospital course: # bleeding esophageal varices: patient was noted to have a hematocrit of 16 on admission to the icu. she received 6 units of prbcs. her ng lavage was negative. she had a egd which showed esophageal varices which were then banded. she had no further bleeding, her hct remained stable, and her dyspnea resolved. she was started on nadolol, protonix, and a 10 day course of levofloxacin given risk for sbp with esophageal varices. the patient will follow up with as an outpatient in approximately one week and will need to be rescoped in a few weeks for further banding. hct at discharge was 38. . # ascites - patient had noted increased abdominal distention prior to admission. u/s noted a large amount of ascites, but no hepatic vein thrombosis. most likely cause of her ascites was the liver metastasis. given a remote hx of ivdu, hepatitis serologies were sent, hepbsab(+) and hepc pending at dischage. patient had a diagnostic paracentesis with no microorganisms seen, no growth to date at dicharge, final results pending. patient was started on lasix and aldactone and will follow up with to address the need for therapeutic paracentesis as an outpatient. . # breast cancer - patient did not receive any chemotherapy during this admission. she will follow up with dr. regarding further treatment. due to difficulty in obtaining iv access in this patient she may benefit from placement of a port-a-cath depending on future treatment plans. . # previous mental status changes - patient did not exhibit any further difficulty with word finding or any other significant mental status changes during her hospitalization. a brain mri was performed on the morning of discharge to evaluate for leptomeningeal carcinomatosis. patient will follow up with dr. to obtain the results from this study. medications on admission: medications on admission 1. concerta 54mg' 2. wellbutrin 150mg 3. lactulose 30ml' 4. ativan 5. phenergan. discharge medications: 1. lactulose 10 g/15 ml syrup sig: thirty (30) ml po daily (daily). 2. methylphenidate 20 mg tablet sustained release sig: three (3) tablet sustained release po daily (). 3. zolpidem 5 mg tablet sig: one (1) tablet po hs (at bedtime). 4. prochlorperazine 5 mg tablet sig: 1-2 tablets po q6h (every 6 hours) as needed for nausea. 5. nadolol 20 mg tablet sig: 0.5 tablet po daily (daily). disp:*15 tablet(s)* refills:*2* 6. levofloxacin 500 mg tablet sig: one (1) tablet po q24h (every 24 hours) for 7 days. disp:*7 tablet(s)* refills:*0* 7. lorazepam 0.5 mg tablet sig: one (1) tablet po q8h (every 8 hours) as needed. 8. furosemide 20 mg tablet sig: 0.5 tablet po daily (daily). disp:*15 tablet(s)* refills:*2* 9. bupropion 150 mg tablet sustained release sig: one (1) tablet sustained release po bid (2 times a day). 10. spironolactone 25 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 11. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q12h (every 12 hours). disp:*60 tablet, delayed release (e.c.)(s)* refills:*2* 12. pramoxine-mineral oil-zinc 1-12.5 % ointment sig: one (1) appl rectal prn (as needed). 13. promethazine 25 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for nausea. discharge disposition: home discharge diagnosis: esophageal bleed esophageal varices metastatic breast cancer discharge condition: good, stable hematocrit discharge instructions: if you develop fevers, chills, lightheadedness, dizziness, shortness of breath, or if you notice bright red blood in your stool or dark tarry stools, call your primary care doctor or return to the emergency room immediately. . you will need to be seen by dr. in gastroenterology within one week. please call ( to make a follow up appointment. . you have a follow up appt with dr. on at 11:30 am. followup instructions: provider: , md phone: date/time: 11:30 provider: , rn phone: date/time: 12:30 provider: 17 date/time: 12:30 md procedure: percutaneous abdominal drainage endoscopic excision or destruction of lesion or tissue of esophagus transfusion of packed cells diagnoses: malignant neoplasm of liver, secondary esophageal varices with bleeding other specified gastritis, without mention of hemorrhage malignant neoplasm of other specified sites of female breast 

Answer: The patient is high likely exposed to